Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Treatment With Convalescent Plasma for Adults With COVID-19 Pneumonia. A Double-blinded, Randomized, Multicenter Placebo-controlled Trial

NCT04345289 is registered in ClinicalTrials.gov with Thomas Benfield as lead sponsor.

NCT NCT04345289
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04345289 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Treatment With Convalescent Plasma for Adults With COVID-19 Pneumonia. A Double-blinded, Randomized, Multicenter Placebo-controlled Trial
Lead sponsor
Thomas Benfield
Phase
Phase 3
Overall status
Terminated
Start date
May 1, 2020
Completion date
March 16, 2021
Enrollment
147 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

corona virus infection, covid, viral pneumonia